YU33394A - Postupak za prevođenje lorakarbif dihidrata u lorakarbif monohidrat - Google Patents

Postupak za prevođenje lorakarbif dihidrata u lorakarbif monohidrat

Info

Publication number
YU33394A
YU33394A YU33394A YU33394A YU33394A YU 33394 A YU33394 A YU 33394A YU 33394 A YU33394 A YU 33394A YU 33394 A YU33394 A YU 33394A YU 33394 A YU33394 A YU 33394A
Authority
YU
Yugoslavia
Prior art keywords
lorakarbif
dihydrate
monohydrate
procedure
transfer
Prior art date
Application number
YU33394A
Other languages
English (en)
Inventor
E.F. Plocharczyk
E.E. Strouse
Original Assignee
Eli Lilly & Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly & Co. filed Critical Eli Lilly & Co.
Publication of YU33394A publication Critical patent/YU33394A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

POSTUPAK ZA PREVOĐENJE LORAKARBIF DIHIDRATA U LORAKARBIF MONOHIDRAT - Postupak za obrazovanje kristalnog monohidratnog oblika jedinjenja formule (I) koji obuhvata izlaganje kristalnog dihidratnog oblika jedinjenja formule (I) na temperaturi od oko 50В°C do oko 65В°C i relativnoj vlažnosti od oko 60 do oko 100 %.
YU33394A 1993-06-04 1994-06-03 Postupak za prevođenje lorakarbif dihidrata u lorakarbif monohidrat YU33394A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/071,550 US5374719A (en) 1993-06-04 1993-06-04 Process for converting loracarbef dihydrate to loracarbef monohydrate

Publications (1)

Publication Number Publication Date
YU33394A true YU33394A (sh) 1996-10-18

Family

ID=22102051

Family Applications (1)

Application Number Title Priority Date Filing Date
YU33394A YU33394A (sh) 1993-06-04 1994-06-03 Postupak za prevođenje lorakarbif dihidrata u lorakarbif monohidrat

Country Status (29)

Country Link
US (1) US5374719A (sh)
EP (1) EP0627430B1 (sh)
JP (1) JP3442479B2 (sh)
KR (1) KR100311699B1 (sh)
CN (1) CN1042424C (sh)
AT (1) ATE146472T1 (sh)
AU (1) AU678000B2 (sh)
BR (1) BR9402149A (sh)
CA (1) CA2125001C (sh)
CO (1) CO4230100A1 (sh)
CZ (1) CZ283468B6 (sh)
DE (1) DE69401163T2 (sh)
DK (1) DK0627430T3 (sh)
ES (1) ES2097002T3 (sh)
FI (1) FI108132B (sh)
GR (1) GR3022111T3 (sh)
HU (1) HU217066B (sh)
IL (1) IL109871A (sh)
MY (1) MY110724A (sh)
NO (1) NO306302B1 (sh)
NZ (1) NZ260653A (sh)
PE (1) PE13195A1 (sh)
PH (1) PH30304A (sh)
PL (1) PL174539B1 (sh)
RU (1) RU2124013C1 (sh)
TW (1) TW252980B (sh)
UA (1) UA27812C2 (sh)
YU (1) YU33394A (sh)
ZA (1) ZA943827B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
US20070225285A1 (en) * 2005-11-04 2007-09-27 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (flap) inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3502663A (en) * 1969-04-21 1970-03-24 Lilly Co Eli Crystalline cephalosporin,method for its manufacture
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
MY104063A (en) * 1987-10-06 1993-11-30 Lilly Co Eli Crystalline (beta)-lactam hydrate
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic

Also Published As

Publication number Publication date
NZ260653A (en) 1995-12-21
KR950000701A (ko) 1995-01-03
UA27812C2 (uk) 2000-10-16
HU217066B (hu) 1999-11-29
RU2124013C1 (ru) 1998-12-27
DE69401163D1 (de) 1997-01-30
NO942048L (no) 1994-12-05
FI942633A0 (fi) 1994-06-03
FI942633A (fi) 1994-12-05
DK0627430T3 (da) 1997-06-02
HU9401675D0 (en) 1994-09-28
NO942048D0 (no) 1994-06-02
FI108132B (fi) 2001-11-30
ZA943827B (en) 1995-12-01
CA2125001C (en) 2004-08-03
PE13195A1 (es) 1995-05-24
TW252980B (sh) 1995-08-01
NO306302B1 (no) 1999-10-18
ES2097002T3 (es) 1997-03-16
IL109871A (en) 1998-08-16
CO4230100A1 (es) 1995-10-19
IL109871A0 (en) 1994-10-07
JPH06345763A (ja) 1994-12-20
AU6451694A (en) 1994-12-08
US5374719A (en) 1994-12-20
GR3022111T3 (en) 1997-03-31
EP0627430A1 (en) 1994-12-07
JP3442479B2 (ja) 2003-09-02
CN1097754A (zh) 1995-01-25
HUT67743A (en) 1995-04-28
RU94019424A (ru) 1996-04-20
PH30304A (en) 1997-02-20
KR100311699B1 (ko) 2001-12-28
BR9402149A (pt) 1994-12-27
CZ283468B6 (cs) 1998-04-15
PL174539B1 (pl) 1998-08-31
EP0627430B1 (en) 1996-12-18
PL303676A1 (en) 1994-12-12
MY110724A (en) 1999-01-30
CZ134294A3 (en) 1994-12-15
DE69401163T2 (de) 1997-04-30
CA2125001A1 (en) 1994-12-05
ATE146472T1 (de) 1997-01-15
AU678000B2 (en) 1997-05-15
CN1042424C (zh) 1999-03-10

Similar Documents

Publication Publication Date Title
FI875502A (fi) Morfolinoetylester av mykofenolsyra och dess derivat
ATE52766T1 (de) 2-oxyimino-3-oxo-buttersaeurederivate und deren herstellungsverfahren.
YU33394A (sh) Postupak za prevođenje lorakarbif dihidrata u lorakarbif monohidrat
HU9401673D0 (en) Loracarbe-isopropanolate and a process for converting it to monohydrate
AU683790B2 (en) Nitric esters from derivatives of 2-(2-6-dihalophenylamino) phenylacetoxyacetic acid and their preparation process
MX9100345A (es) Procedimiento para la preparacion de derivados 6-(aminopropionil sustituidos)de forscolina
SE8704542D0 (sv) New derivatives of cysteine
PT92668A (pt) Processo para a preparacao de derivados de azabiciclo-heptano
MX9706606A (es) Procedimiento para la preparacion del monohidrato de loracarbef.